National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Announcement of the Availability of the Bisphenol A Expert Panel Report; Request for Public Comment, 67730-67731 [E7-23234]
Download as PDF
<![CDATA[
67730
Federal Register / Vol. 72, No. 230 / Friday, November 30, 2007 / Notices
Avenue, SW., Room 450G, Washington,
DC 20201; 202–205–3815; fax: 202–690–
7412; e-mail address:
leigh.sawyer@hhs.gov.
Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d–7f) as
added by section 402 of the Pandemic
and All-Hazards Preparedness Act (Pub.
L. 109–417) the Secretary of Health and
Human Services is required to establish
the National Biodefense Science Board
and hold the inaugural meeting of the
Board prior to December 19, 2007.
The Board shall provide expert advice
and guidance to the Secretary on
scientific, technical and other matters of
special interest to the Department of
Health and Human Services regarding
current and future chemical, biological,
nuclear, and radiological (CBRN) agents,
whether naturally occurring, accidental,
or deliberate.
The agenda will include topics related
to current and future challenges to
national preparedness related to CBRN
agents, and will include discussions
regarding matters that the Board will
consider in greater depth. A tentative
schedule will be made available on
December 2, 2007 at the NBSB Web site,
https://www.hhs.gov/aspr/omsph/nbsb.
Any member of the public interested
in presenting oral comments at the
meeting may notify the Contact person
listed on this notice by December 10,
2007. Interested individuals and
representatives of an organization may
submit a letter of intent and a brief
description of the organization
represented. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee.
All written comments must be received
prior to December 10, 2007 and should
be sent by e-mail with ‘‘NBSB Public
Comment’’ as the subject line or by
regular mail to the Contact person listed
above. Individuals who plan to attend
and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
notify the designated Contact person by
December 10, 2007.
rwilkins on PROD1PC63 with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: November 26, 2007.
RADM W. Craig Vanderwagen,
Assistant Secretary for Preparedness and
Response, U.S. Department of Health and
Human Services.
[FR Doc. 07–5885 Filed 11–29–07; 8:45 am]
BILLING CODE 4150–37–M
VerDate Aug<31>2005
16:27 Nov 29, 2007
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Committee on Vital and Health
Statistics: Meeting
Dated: November 19, 2007.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation (SDP), Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 07–5876 Filed 11–29–07; 8:45 am]
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
BILLING CODE 4151–05–M
Name: National Committee on Vital and
Health Statistics (NCVHS).
Time and Date: November 27, 2007 9 a.m.–
3:45 p.m. November 28, 2007 10 a.m.–3 p.m.
Place: Hilton Embassy Row Hotel, 2015
Massachusetts Avenue NW., Washington,
DC, 202–265–1600.
Status: Open.
Purpose: At this meeting the Committee
will hear presentations and hold discussions
on several health data policy topics. On the
morning and afternoon of the first day the
Committee will hear updates from the
Department and status reports from its
subcommittees as well as a presentation from
the Robert Graham Center on harmonizing
primary care standards.
On the morning of the second day the
Committee will hear an update from the
Office of the National Coordinator for Health
Information Technology (ONCHIT) followed
by Committee actions on selected topics from
the subcommittees. In the afternoon there
will be a follow up discussion to the ONCHIT
presentation and an update from the
subcommittees on current and planned
activities. There will be a short discussion of
future agendas before the meeting adjourns.
The times shown above are for the full
Committee meeting. Subcommittee breakout
sessions are scheduled for late in the
afternoon of the first day in the morning prior
to the full Committee meeting on the second
day. Agendas for these breakout sessions will
be posted on the NCVHS Web site (URL
below) when available.
National Toxicology Program (NTP);
Center for the Evaluation of Risks to
Human Reproduction (CERHR);
Announcement of the Availability of
the Bisphenol A Expert Panel Report;
Request for Public Comment
FOR FURTHER INFORMATION CONTACT:
Substantive program information as
well as summaries of meetings and a
roster of committee members may be
obtained from Marjorie S. Greenberg,
Executive Secretary, NCVHS, National
Center for Health Statistics, Centers for
Disease Control and Prevention, 3311
Toledo Road, Room 2402, Hyattsville,
Maryland 20782, telephone (301) 458–
4245. Information also is available on
the NCVHS home page of the HHS Web
Site: https://www.ncvhs.hhs.gov/, where
further information including an agenda
will be posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on (301) 458–4EEO (4336)
as soon as possible.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH).
AGENCY:
Announcement of report
availability and request for comment.
ACTION:
SUMMARY: CERHR announces the
availability of the final bisphenol A
expert panel report on November 26,
2007, from the CERHR Web site (https://
cerhr.niehs.nih.gov) or in print from
CERHR (see ADDRESSES below). The
expert panel report is an evaluation of
the reproductive and developmental
toxicity of bisphenol A conducted by an
independent, 12-member expert panel
composed of scientists from the public
and private sectors convened by
CERHR. CERHR invites the submission
of public comments on this report (see
SUPPLEMENTARY INFORMATION below).
The expert panel met twice in public
session (March 5–7, 2007 and August 6–
8, 2007) to review and revise the draft
expert panel report and reach
conclusions regarding whether exposure
to bisphenol A is a hazard to human
development or reproduction. The
expert panel also identified data gaps
and research needs.
The final bisphenol A expert
panel report will be available for public
comment on November 26, 2007.
Written public comments on this report
should be received by January 25, 2008.
DATES:
Comments on the expert
panel report and any other
correspondence should be sent to Dr.
Michael D. Shelby, CERHR Director,
NIEHS, P.O. Box 12233, MD EC–32,
Research Triangle Park, NC 27709, fax:
(919) 316–4511, or e-mail:
shelby@niehs.nih.gov. Courier address:
CERHR, 79 T.W. Alexander Drive,
Building 4401, Room 103, Research
Triangle Park, NC 27709.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\30NON1.SGM
30NON1
Federal Register / Vol. 72, No. 230 / Friday, November 30, 2007 / Notices
Background
Bisphenol A (CAS RN: 80–5–07) is a
high production volume chemical used
in the production of epoxy resins,
polyester resins, polysulfone resins,
polyacrylate resins, polycarbonate
plastics, and flame retardants.
Polycarbonate plastics are used in food
and drink packaging; resins are used as
lacquers to coat metal products such as
food cans, bottle tops, and water supply
pipes. Some polymers used in dental
sealants and tooth coatings contain
bisphenol A. Exposure to the general
population can occur through direct
contact to bisphenol A or by exposure
to food or drink that has been in contact
with a material containing bisphenol A.
CERHR selected this chemical for
evaluation because of (1) high
production volume, (2) widespread
human exposure, (3) evidence of
reproductive toxicity in laboratory
animal studies, and (4) public concern.
The CERHR convened an expert panel
on March 5–7, 2007, and on August 6–
8, 2007, to review and revise the draft
and interim draft expert panel reports
and reach conclusions regarding
whether exposure to bisphenol A is a
hazard to human development or
reproduction. The expert panel also
identified data gaps and research needs.
CERHR solicited public comments on
drafts of the expert panel report several
times (FR, December 12, 2006, Vol. 71,
No. 238 pp. 74534–74536; FR, April 2,
2007, Vol. 72, No. 62 pp. 15695–15696;
FR, May 1, 2007, Vol. 72, No. 83 pp.
23833–23834).
Following receipt of public comments
on the final bisphenol A expert panel
report, CERHR staff will prepare the
NTP–CERHR monograph. NTP–CERHR
monographs are divided into four major
sections: (1) The NTP Brief that
provides the NTP’s interpretation of the
potential for the chemical to cause
adverse reproductive and/or
developmental effects in exposed
humans, (2) a roster of expert panel
members, (3) the final expert panel
report, and (4) public comments
received on that report. The NTP Brief
is based on the expert panel report,
public comments on that report, public
and peer review comments on the draft
NTP Brief, and any new, relevant
information that becomes available after
the expert panel meetings.
rwilkins on PROD1PC63 with NOTICES
Request for Comments
CERHR invites written public
comments on the bisphenol A expert
panel report. Written comments should
be sent to Dr. Michael Shelby (see
ADDRESSES above). Persons submitting
written comments are asked to include
VerDate Aug<31>2005
16:27 Nov 29, 2007
Jkt 214001
their name and contact information
(affiliation, mailing address, telephone
and facsimile numbers, e-mail, and
sponsoring organization, if any). Any
comments received will be posted on
the CERHR Web site and included in the
NTP CERHR monograph on this
chemical. All public comments will be
considered by the NTP during
preparation of the NTP Brief (see
‘‘Background’’ above).
Background Information on CERHR
The NTP established the CERHR in
June 1998 [FR, December 14, 1998 (Vol.
63, No. 239, pp. 68782)]. CERHR is a
publicly accessible resource for
information about adverse reproductive
and/or developmental health effects
associated with exposure to
environmental and/or occupational
exposures. Expert panels conduct
scientific evaluations of agents selected
by CERHR in public forums.
CERHR invites the nomination of
agents for review or scientists for its
expert registry. Information about
CERHR and the nomination process can
be obtained from its Web site (https://
cerhr.niehs.nih.gov) or by contacting Dr.
Shelby (see ADDRESSES above). CERHR
selects chemicals for evaluation based
upon several factors including
production volume, potential for human
exposure from use and occurrence in
the environment, extent of public
concern, and extent of data from
reproductive and developmental
toxicity studies.
CERHR follows a formal, multi-step
process for review and evaluation of
selected chemicals. A description of the
evaluation process is available on the
CERHR Web site under ‘‘About CERHR’’
or in printed copy from CERHR.
Dated: November 15, 2007.
Samuel H. Wilson,
Acting Director, National Institute of
Environmental Health Sciences and National
Toxicology Program.
[FR Doc. E7–23234 Filed 11–29–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Amendment to January 26, 2007
Declaration Under the Public
Readiness and Emergency
Preparedness Act
Office of the Assistant
Secretary for Preparedness and
Response (ASPR), HHS.
AGENCY:
Amendment (to the January 26,
2007 Declaration under the Public
ACTION:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
67731
Readiness and Emergency Preparedness
Act).
SUMMARY: Declaration pursuant to
section 319F–3 of the Public Health
Service Act (42 U.S.C. 247d–6d) to
provide targeted liability protections for
pandemic countermeasures based on a
credible risk that avian influenza
viruses spread and evolve into strains
capable of causing a pandemic of
human influenza.
Amendment: Whereas, the H7 and H9
subtypes of avian influenza viruses are
viewed as likely candidates to evolve
into an influenza virus strain capable of
causing a pandemic of human influenza;
and
Whereas, in accordance with section
319F–3(b)(6) of the Public Health
Service Act (42 U.S.C. 247d–6d(b)) (‘‘the
Act’’), I have considered the desirability
of encouraging the design, development,
clinical testing or investigation,
manufacturing and product formulation,
labeling, distribution, packaging,
marketing, promotion, sale, purchase,
donation, dispensing, prescribing,
administration, licensing, and use of
these additional medical
countermeasures with respect to the
category of diseases and population
described in sections II and IV of the
declaration published in Federal
Register on February 1, 2007 (72 FR
4710) (‘‘the Original Declaration’’);
Therefore, pursuant to section 319F–
3(b) of the Act, I have determined there
is a credible risk that the spread of the
H7 and H9 subtypes of avian influenza
viruses and resulting disease could in
the future constitute a public health
emergency. In order to reflect the
addition of medical countermeasures
specific to the H7 and H9 subtypes of
influenza viruses, the Original
Declaration is hereby amended as
follows:
First ‘‘whereas’’ clause, first sentence,
insert ‘‘H7 and H9 vaccines’’ following
‘‘(H5N1).’’
Second ‘‘whereas’’ clause, first
sentence, insert ‘‘H7 and H9’’ following
‘‘H5N1’’ to read ‘‘Whereas an H5N1, [H7
and H9] avian influenza viruse[s] may
evolve into strain[s] * * *.’’
In Section I, paragraph 2, first
sentence insert ‘‘H7 and H9’’ following
‘‘(H5N1)’’ to read ‘‘* * * pandemic
countermeasure influenza A (H5N1, [H7
and H9]) vaccine[s].’’
In Section I, paragraph 2, third
sentence insert ‘‘H7 and H9’’ following
‘‘(H5N1)’’ to read ‘‘* * * pandemic
countermeasure influenza A (H5N1, [H7
and H9]) vaccine[s] * * *.’’
In Section II, paragraph 1, insert ‘‘or
an H7 or H9’’ following ‘‘(H5N1).’’
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 72, Number 230 (Friday, November 30, 2007)]
[Notices]
[Pages 67730-67731]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-23234]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Toxicology Program (NTP); Center for the Evaluation of
Risks to Human Reproduction (CERHR); Announcement of the Availability
of the Bisphenol A Expert Panel Report; Request for Public Comment
AGENCY: National Institute of Environmental Health Sciences (NIEHS);
National Institutes of Health (NIH).
ACTION: Announcement of report availability and request for comment.
-----------------------------------------------------------------------
SUMMARY: CERHR announces the availability of the final bisphenol A
expert panel report on November 26, 2007, from the CERHR Web site
(https://cerhr.niehs.nih.gov) or in print from CERHR (see ADDRESSES
below). The expert panel report is an evaluation of the reproductive
and developmental toxicity of bisphenol A conducted by an independent,
12-member expert panel composed of scientists from the public and
private sectors convened by CERHR. CERHR invites the submission of
public comments on this report (see SUPPLEMENTARY INFORMATION below).
The expert panel met twice in public session (March 5-7, 2007 and
August 6-8, 2007) to review and revise the draft expert panel report
and reach conclusions regarding whether exposure to bisphenol A is a
hazard to human development or reproduction. The expert panel also
identified data gaps and research needs.
DATES: The final bisphenol A expert panel report will be available for
public comment on November 26, 2007. Written public comments on this
report should be received by January 25, 2008.
ADDRESSES: Comments on the expert panel report and any other
correspondence should be sent to Dr. Michael D. Shelby, CERHR Director,
NIEHS, P.O. Box 12233, MD EC-32, Research Triangle Park, NC 27709, fax:
(919) 316-4511, or e-mail: shelby@niehs.nih.gov. Courier address:
CERHR, 79 T.W. Alexander Drive, Building 4401, Room 103, Research
Triangle Park, NC 27709.
SUPPLEMENTARY INFORMATION:
[[Page 67731]]
Background
Bisphenol A (CAS RN: 80-5-07) is a high production volume chemical
used in the production of epoxy resins, polyester resins, polysulfone
resins, polyacrylate resins, polycarbonate plastics, and flame
retardants. Polycarbonate plastics are used in food and drink
packaging; resins are used as lacquers to coat metal products such as
food cans, bottle tops, and water supply pipes. Some polymers used in
dental sealants and tooth coatings contain bisphenol A. Exposure to the
general population can occur through direct contact to bisphenol A or
by exposure to food or drink that has been in contact with a material
containing bisphenol A. CERHR selected this chemical for evaluation
because of (1) high production volume, (2) widespread human exposure,
(3) evidence of reproductive toxicity in laboratory animal studies, and
(4) public concern.
The CERHR convened an expert panel on March 5-7, 2007, and on
August 6-8, 2007, to review and revise the draft and interim draft
expert panel reports and reach conclusions regarding whether exposure
to bisphenol A is a hazard to human development or reproduction. The
expert panel also identified data gaps and research needs. CERHR
solicited public comments on drafts of the expert panel report several
times (FR, December 12, 2006, Vol. 71, No. 238 pp. 74534-74536; FR,
April 2, 2007, Vol. 72, No. 62 pp. 15695-15696; FR, May 1, 2007, Vol.
72, No. 83 pp. 23833-23834).
Following receipt of public comments on the final bisphenol A
expert panel report, CERHR staff will prepare the NTP-CERHR monograph.
NTP-CERHR monographs are divided into four major sections: (1) The NTP
Brief that provides the NTP's interpretation of the potential for the
chemical to cause adverse reproductive and/or developmental effects in
exposed humans, (2) a roster of expert panel members, (3) the final
expert panel report, and (4) public comments received on that report.
The NTP Brief is based on the expert panel report, public comments on
that report, public and peer review comments on the draft NTP Brief,
and any new, relevant information that becomes available after the
expert panel meetings.
Request for Comments
CERHR invites written public comments on the bisphenol A expert
panel report. Written comments should be sent to Dr. Michael Shelby
(see ADDRESSES above). Persons submitting written comments are asked to
include their name and contact information (affiliation, mailing
address, telephone and facsimile numbers, e-mail, and sponsoring
organization, if any). Any comments received will be posted on the
CERHR Web site and included in the NTP CERHR monograph on this
chemical. All public comments will be considered by the NTP during
preparation of the NTP Brief (see ``Background'' above).
Background Information on CERHR
The NTP established the CERHR in June 1998 [FR, December 14, 1998
(Vol. 63, No. 239, pp. 68782)]. CERHR is a publicly accessible resource
for information about adverse reproductive and/or developmental health
effects associated with exposure to environmental and/or occupational
exposures. Expert panels conduct scientific evaluations of agents
selected by CERHR in public forums.
CERHR invites the nomination of agents for review or scientists for
its expert registry. Information about CERHR and the nomination process
can be obtained from its Web site (https://cerhr.niehs.nih.gov) or by
contacting Dr. Shelby (see ADDRESSES above). CERHR selects chemicals
for evaluation based upon several factors including production volume,
potential for human exposure from use and occurrence in the
environment, extent of public concern, and extent of data from
reproductive and developmental toxicity studies.
CERHR follows a formal, multi-step process for review and
evaluation of selected chemicals. A description of the evaluation
process is available on the CERHR Web site under ``About CERHR'' or in
printed copy from CERHR.
Dated: November 15, 2007.
Samuel H. Wilson,
Acting Director, National Institute of Environmental Health Sciences
and National Toxicology Program.
[FR Doc. E7-23234 Filed 11-29-07; 8:45 am]
BILLING CODE 4140-01-P
